We are thrilled that our recent study lead by @BayerlFelix is out in @ImmunityCP today. We addressed the question how cDC1 dysfunction is regulated in tumors and to which extent this contributes to cancer immune evasion. It is Open Access!👇 cell.com/immunity/fulltext/S… A short 🧵:

Jun 13, 2023 · 3:13 PM UTC

16
54
220
45,324
In our study, we find that PGE2, a bioactive lipid produced by many mouse and human cancers, drives immune evasion by rendering cDC1 dysfunctional, foremost with respect to their ability to communicate with tumor-infiltrating CD8+ T cells.
1
690
How is this achieved? Our data suggest that PGE2 targets the transcription factor IRF8 in intratumoral cDC1, disabling the local orchestration of anti-cancer CD8+ T cell responses in the TME. This indicates a role for IRF8 in differentiated cDC1, beyond its role in DC development
1
555
We went on and identified PGE2 signaling through the PGE2 receptors EP2/EP4 responsible for cDC1 dysfunction. Strikingly, ablation of EP2 and EP4 on cDC1 prevented their dysfunction in tumors, permitting cDC1 to instruct effective CD8+ T cell responses that achieve tumor control.
1
500
Of note, our data indicate that this inhibitory mechanisms similarly applies to cDC1 dysfunction in human tumors. It may therefore be explored as target for novel cancer therapies aiming at promoting more effective anti-cancer immune responses in tumor tissue.
1
505
We hope that our findings are of interest to many researchers in the field of immunology and oncology, especially those interested in harnessing the power of DCs for cancer therapy
1
3
530
We are very greatful for the fantatstic support not only by the entire lab but also many fantastic colleagues and collaboration partners, including @buschraml @VeitBuchholz @AlfredZippelius @obenaufa and generous funding from @dfg_public and the EliteNetwork of Bavaria.
1
1
2
1,776
Sort replies: Relevant Recent Liked
Congrats, Jan! Great work.
1
1
280
Thanks Ping-Chih!
1
235
So beautiful work!Congrats,Prof.Jan P.Bottcher。We know that Nk cells are the main target of PGE2,so What is the contribution of pge2 to the inhibition of DC cells in tumor immunity?Thanks
1
254
In our study, we used cell type specific EP2/EP4-KO models to explore to which extent PGE2-mediated inhibition of NK cells vs cDC1 contributes to cancer immune escape. Our data suggest that cDC1 suppression is critical, suppression of NKs contributes albeit to a lesser extent.
1
305
Sounds very interesting. Do you know if pathogens can exploit this pathway to impair immune responses? Most CD8 T cell responses seem to be cDC1 mediated.
1
110
We haven’t investigated this ourselves, but there are, for example, many reports on PGE2 during type 2 inflammation and exploitation of this pathway by helminth.
70
Congratulations! Very happy to see this out.
1
2
294
Great study (and thread)! Nice to see this out, looking forward to reading it in detail. Congrats 🎉
1
85
Congrats @JBoettcherLab and @BayerlFelix for this very elegant work. I’m glad this is out!
1
89
Very nice story! Great DC migration, cytokine, and T cell interaction data. Congratulations!
1
196
Congratulations, Jan! Very interesting and important study! Very good start as a group leader! We are lucky to have your team in our Institute 😊
1
176
Congrats Jan!!!!! 👏🏼👏🏼👏🏼
1
65
Congrats Jan et al! Can't wait to read
1
119
Congratulations! Wonderful work!
1
131
Interesting..these are connected to mechanisms causing miscarriages.
42